Oncolytics Biotech (ONCY) to Release Earnings on Thursday

Oncolytics Biotech (NASDAQ:ONCYGet Rating) is scheduled to post its quarterly earnings results before the market opens on Thursday, August 11th. Analysts expect Oncolytics Biotech to post earnings of ($0.09) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Oncolytics Biotech (NASDAQ:ONCYGet Rating) last released its earnings results on Thursday, May 5th. The company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.13) by $0.04. On average, analysts expect Oncolytics Biotech to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Oncolytics Biotech Price Performance

Shares of NASDAQ ONCY opened at $1.21 on Thursday. The company has a market capitalization of $70.02 million, a price-to-earnings ratio of -3.18 and a beta of 2.26. The business has a 50-day moving average of $1.04 and a two-hundred day moving average of $1.38. Oncolytics Biotech has a 1 year low of $0.80 and a 1 year high of $2.38.

Oncolytics Biotech Company Profile

(Get Rating)

Oncolytics Biotech Inc, a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies.

Featured Stories

Earnings History for Oncolytics Biotech (NASDAQ:ONCY)

Want More Great Investing Ideas?

Receive News & Ratings for Oncolytics Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncolytics Biotech and related companies with MarketBeat.com's FREE daily email newsletter.